Literature DB >> 16442932

Coronary artery disease in minority racial and ethnic groups in the United States.

Keith C Ferdinand1.   

Abstract

Racial/ethnic minorities in the United States have a risk for coronary artery disease (CAD) that is at least equivalent to that in the white majority. African Americans have greater cardiovascular mortality rates and greater risk for early mortality caused by CAD. Risk may be associated with a greater clustering of risk factors in African Americans and other minority groups and may be associated with inadequate screening and evidence-based treatment of these groups in clinical practice. Data are beginning to emerge showing racial/ethnic variation in levels of the inflammatory marker high-sensitivity C-reactive protein, with higher levels in African Americans than in whites. There remain significant challenges to understanding racial/ethnic differences in cardiovascular risk factors and to including minority groups in clinical trials of therapeutic interventions, thereby ensuring optimal treatment for all.

Entities:  

Mesh:

Year:  2005        PMID: 16442932     DOI: 10.1016/j.amjcard.2005.11.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  32 in total

1.  Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

Authors:  Michel C F Shamy; Clement Zai; Vincenzo S Basile; James L Kennedy; Daniel J Müller; Mario Masellis
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-06-01

2.  Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study.

Authors:  Jiankang Liu; Caroline S Fox; DeMarc Hickson; Aurelian Bidulescu; J Jeffery Carr; Herman A Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

3.  Sex and race (black-white) differences in the relationship of childhood risk factors to adulthood arterial stiffness: the Bogalusa Heart Study.

Authors:  Shengxu Li; Wei Chen; Miaoying Yun; Camilo Fernandez; Marie Krousel-Wood; Larry Webber; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

4.  Arachidonate 5-lipoxygenase gene variants affect response to fish oil supplementation by healthy African Americans.

Authors:  Patrice Armstrong; Darshan S Kelley; John W Newman; Frank E Staggers; Janna Hartiala; Hooman Allayee; Charles B Stephensen
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

5.  Chronic discrimination predicts higher circulating levels of E-selectin in a national sample: the MIDUS study.

Authors:  Elliot M Friedman; David R Williams; Burton H Singer; Carol D Ryff
Journal:  Brain Behav Immun       Date:  2009-01-11       Impact factor: 7.217

6.  Racial and socioeconomic disparities in arterial stiffness and intima media thickness among adolescents.

Authors:  Rebecca C Thurston; Karen A Matthews
Journal:  Soc Sci Med       Date:  2009-01-13       Impact factor: 4.634

7.  Barriers to obtaining diagnostic testing for coronary artery disease among veterans.

Authors:  Laura A Siminoff; Leslie R M Hausmann; Said Ibrahim
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

8.  Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study.

Authors:  Jiankang Liu; Solomon K Musani; Aurelian Bidulescu; J Jeffery Carr; James G Wilson; Herman A Taylor; Caroline S Fox
Journal:  Atherosclerosis       Date:  2012-08-10       Impact factor: 5.162

Review 9.  New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Authors:  Karim R Saab; Jessica Kendrick; Joseph M Yracheta; Miguel A Lanaspa; Maisha Pollard; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 10.121

10.  Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study.

Authors:  Maryam Afkarian; Ronit Katz; Nisha Bansal; Adolfo Correa; Bryan Kestenbaum; Jonathan Himmelfarb; Ian H de Boer; Bessie Young
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.